Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ryanodine Receptor Calcium Release Channel | 15 | 2025 | 239 | 3.360 |
Why?
|
| Muscle, Skeletal | 17 | 2025 | 973 | 3.280 |
Why?
|
| Calcium | 15 | 2025 | 1031 | 2.510 |
Why?
|
| Malignant Hyperthermia | 9 | 2025 | 18 | 2.270 |
Why?
|
| Tacrolimus Binding Protein 1A | 5 | 2024 | 21 | 1.560 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2024 | 207 | 1.500 |
Why?
|
| Sarcoplasmic Reticulum | 7 | 2025 | 146 | 1.440 |
Why?
|
| Heat Stroke | 2 | 2025 | 6 | 1.240 |
Why?
|
| Calcium Channels, L-Type | 5 | 2025 | 49 | 0.970 |
Why?
|
| Calcium Signaling | 6 | 2025 | 241 | 0.920 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2021 | 122 | 0.780 |
Why?
|
| Muscular Diseases | 2 | 2021 | 116 | 0.750 |
Why?
|
| Mutation | 5 | 2021 | 5950 | 0.740 |
Why?
|
| Calcium-Binding Proteins | 4 | 2022 | 327 | 0.710 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2021 | 37 | 0.670 |
Why?
|
| Thermogenesis | 1 | 2020 | 50 | 0.650 |
Why?
|
| Heat Stress Disorders | 2 | 2022 | 9 | 0.560 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2020 | 590 | 0.540 |
Why?
|
| Mitochondria, Muscle | 2 | 2015 | 36 | 0.540 |
Why?
|
| Animals | 28 | 2025 | 33214 | 0.530 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 55 | 0.500 |
Why?
|
| Muscle Proteins | 4 | 2025 | 398 | 0.500 |
Why?
|
| Mice | 20 | 2025 | 17695 | 0.500 |
Why?
|
| Software | 1 | 2020 | 712 | 0.470 |
Why?
|
| CD36 Antigens | 1 | 2015 | 33 | 0.470 |
Why?
|
| Calmodulin | 3 | 2010 | 206 | 0.440 |
Why?
|
| Sirolimus | 2 | 2014 | 223 | 0.440 |
Why?
|
| Calsequestrin | 4 | 2021 | 12 | 0.420 |
Why?
|
| Hot Temperature | 2 | 2012 | 138 | 0.420 |
Why?
|
| Ligands | 1 | 2014 | 477 | 0.390 |
Why?
|
| Fatty Acids | 1 | 2015 | 351 | 0.390 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2012 | 18 | 0.370 |
Why?
|
| Death, Sudden | 2 | 2012 | 44 | 0.360 |
Why?
|
| Ribonucleotides | 1 | 2012 | 31 | 0.360 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 169 | 0.330 |
Why?
|
| Oxidative Stress | 3 | 2024 | 757 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 4513 | 0.280 |
Why?
|
| Mice, Mutant Strains | 4 | 2017 | 366 | 0.240 |
Why?
|
| Muscle Contraction | 4 | 2022 | 151 | 0.240 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 493 | 0.240 |
Why?
|
| Excitation Contraction Coupling | 1 | 2025 | 14 | 0.240 |
Why?
|
| Peptides | 1 | 2009 | 830 | 0.230 |
Why?
|
| Point Mutation | 2 | 2025 | 335 | 0.230 |
Why?
|
| Serine | 1 | 2025 | 160 | 0.220 |
Why?
|
| Myocardium | 2 | 2024 | 845 | 0.220 |
Why?
|
| Phosphorylation | 3 | 2025 | 1538 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2015 | 139 | 0.200 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 2023 | 65 | 0.200 |
Why?
|
| Immunoprecipitation | 1 | 2023 | 187 | 0.200 |
Why?
|
| Muscle Weakness | 1 | 2023 | 86 | 0.190 |
Why?
|
| Models, Molecular | 3 | 2010 | 1058 | 0.180 |
Why?
|
| Exons | 1 | 2023 | 757 | 0.170 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 2312 | 0.170 |
Why?
|
| Mice, Inbred mdx | 1 | 2020 | 43 | 0.170 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 31 | 0.170 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 33 | 0.170 |
Why?
|
| Lactates | 1 | 2020 | 78 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 579 | 0.170 |
Why?
|
| Reactive Nitrogen Species | 2 | 2012 | 8 | 0.160 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 48 | 0.160 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 85 | 0.160 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2020 | 65 | 0.160 |
Why?
|
| Protein Binding | 3 | 2014 | 1664 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 650 | 0.150 |
Why?
|
| Amino Acid Motifs | 2 | 2009 | 187 | 0.140 |
Why?
|
| Mice, Knockout | 5 | 2020 | 3720 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2020 | 552 | 0.140 |
Why?
|
| TRPV Cation Channels | 1 | 2018 | 45 | 0.140 |
Why?
|
| Muscle Strength | 2 | 2008 | 79 | 0.140 |
Why?
|
| Mitochondria | 2 | 2017 | 729 | 0.140 |
Why?
|
| Male | 10 | 2021 | 62900 | 0.130 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 425 | 0.120 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2022 | 101 | 0.120 |
Why?
|
| Nitric Oxide Synthase | 1 | 2015 | 169 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2014 | 415 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 167 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 191 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 578 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2015 | 296 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1601 | 0.100 |
Why?
|
| Phenotype | 3 | 2020 | 4309 | 0.100 |
Why?
|
| Hypothermia | 1 | 2013 | 63 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 720 | 0.100 |
Why?
|
| Isometric Contraction | 2 | 2008 | 23 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2017 | 1011 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 565 | 0.090 |
Why?
|
| Crystallography, X-Ray | 2 | 2009 | 357 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2017 | 4489 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 533 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 266 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2015 | 762 | 0.080 |
Why?
|
| Apoptosis | 1 | 2017 | 1823 | 0.080 |
Why?
|
| Caffeine | 3 | 2022 | 65 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 158 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 83 | 0.080 |
Why?
|
| Humans | 11 | 2025 | 127519 | 0.080 |
Why?
|
| Raptors | 1 | 2008 | 6 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 299 | 0.070 |
Why?
|
| Nitrosation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Rhabdomyolysis | 1 | 2008 | 35 | 0.070 |
Why?
|
| Long-Term Potentiation | 1 | 2008 | 106 | 0.070 |
Why?
|
| Mammals | 1 | 2009 | 247 | 0.070 |
Why?
|
| Oxidants | 1 | 2008 | 23 | 0.070 |
Why?
|
| Superoxides | 1 | 2008 | 129 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4448 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3271 | 0.070 |
Why?
|
| Fear | 1 | 2008 | 201 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 136 | 0.070 |
Why?
|
| Protein Conformation | 1 | 2009 | 802 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 566 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2008 | 318 | 0.070 |
Why?
|
| Cryoelectron Microscopy | 1 | 2008 | 226 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2007 | 70 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 2025 | 1569 | 0.060 |
Why?
|
| Young Adult | 1 | 2020 | 9707 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2007 | 188 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 780 | 0.060 |
Why?
|
| Infant | 1 | 2020 | 12811 | 0.060 |
Why?
|
| Action Potentials | 1 | 2008 | 463 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2543 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 14467 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3588 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2009 | 890 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2018 | 119 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 654 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17083 | 0.050 |
Why?
|
| Mixed Function Oxygenases | 1 | 2022 | 36 | 0.050 |
Why?
|
| Adolescent | 1 | 2020 | 20158 | 0.050 |
Why?
|
| Neurons | 2 | 2008 | 1922 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2007 | 1338 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 27894 | 0.040 |
Why?
|
| Child | 1 | 2020 | 25302 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 30611 | 0.040 |
Why?
|
| Zebrafish | 1 | 2022 | 403 | 0.040 |
Why?
|
| Female | 4 | 2020 | 68775 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 224 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2010 | 954 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2008 | 243 | 0.030 |
Why?
|
| Anesthetics | 1 | 2018 | 78 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 826 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 771 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 563 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 31 | 0.030 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2015 | 36 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 52 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 692 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 1487 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 55 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 135 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 278 | 0.020 |
Why?
|
| Torque | 1 | 2008 | 8 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 55 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 102 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 252 | 0.020 |
Why?
|
| Ryanodine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Xanthine | 1 | 2008 | 6 | 0.020 |
Why?
|
| Xanthine Oxidase | 1 | 2008 | 39 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 294 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 237 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2008 | 102 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2008 | 251 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2008 | 125 | 0.020 |
Why?
|
| Organ Size | 1 | 2008 | 429 | 0.020 |
Why?
|
| Glutathione | 1 | 2008 | 195 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 240 | 0.020 |
Why?
|
| Threonine | 1 | 2007 | 61 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 236 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 322 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2008 | 314 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 405 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2008 | 495 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 971 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 461 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1374 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 2314 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6172 | 0.010 |
Why?
|
| Hypertension | 1 | 2007 | 1336 | 0.010 |
Why?
|